FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to dry powder-like pharmaceutical composition for inhalation and to method of its obtaining. Into composition of pharmaceutical composition included are two active ingredients, which represent salmeterol and fluticasone or their pharmaceutically acceptable salts, solvates or esters, two pharmaceutically acceptable excipients, which have value d50 respectively approximately 125-145 mcm and approximately 50-100 mcm and which represent mono- or disaccharides. Method of composition obtaining consists in formation of preliminary mixtures of each of active ingredients and each of pharmaceutically acceptable excipients and mixing two preliminary mixtures with obtaining with fraction of medication, with weight ratio of exipients in said two preliminary mixtures constituting from 1 to 5.
EFFECT: pharmaceutical composition is applied for treating asthma, COLD (chronic obstructive lung disease), allergies and infectious diseases.
6 cl, 7 dwg, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
INHALATION COMPOSITIONS CONTAINING MONTELEUKAST ACID AND PDE-4 INHIBITOR OR INHALATION CORTICOSTEROID | 2008 |
|
RU2470639C2 |
PRE-DOSED DRY POWDER INHALER FOR MOISTURE-SENSITIVE MEDICINES | 2004 |
|
RU2372946C2 |
MEDICAL DRUG CONTAINING TIOTROPIUM IN MOISTURE-PROOF CONTAINER | 2004 |
|
RU2369385C2 |
DEAMORPHIZATION OF SPRAY-DRIED FORMULATIONS VIA SPRAY-BLENDING | 2014 |
|
RU2698331C2 |
NOVEL CARRIER PARTICLES FOR DRY POWDER INHALATION FORMULATIONS | 2020 |
|
RU2823554C1 |
METHOD OF PRODUCING A DRY POWDER COMPOSITION CONTAINING AN ANTICHOLINERGIC, CORTICOSTEROID AND BETA-ADRENERGIC AGENT | 2018 |
|
RU2742376C1 |
METHOD OF PRODUCING A DRY POWDER COMPOSITION CONTAINING AN ANTICHOLINERGIC, CORTICOSTEROID AND BETA-ADRENERGIC AGENT | 2018 |
|
RU2741427C1 |
PHARMACEUTICAL COMPOSITIONS | 2004 |
|
RU2364400C2 |
AGGREGATED PARTICLES | 2013 |
|
RU2666963C2 |
NEW CARRIER PARTICLES FOR DRY POWDER COMPOSITIONS FOR INHALATION | 2018 |
|
RU2745045C1 |
Authors
Dates
2013-09-27—Published
2010-02-18—Filed